Variable | Expert Decisional Support n/N (%) | Academic Detailing alone n/N (%) | Effect Estimate | 95% CI | p-value |
---|---|---|---|---|---|
Primary outcomea | |||||
Receiving anticoagulant therapy (N = 497) | 130/249 (52.2) | 118/248 (47.6) | RR = 1.11 | 0.86–1.43 | 0.42 |
Secondary outcomes | |||||
 Appropriate antithrombotic treatment (N = 443) b | 136/223 (61.0) | 134/220 (60.9) | RR = 1.00 | 0.85–1.19 | 0.97 |
 Appropriate antithrombotic incorporating quality control criteria (N = 443) b | 91/223 (40.8) | 99/220 (45.0) | RR = 0.91 | 0.73–1.14 | 0.43 |
 Decisional Conflict (N = 497) | Mean = 16 95% CI = 15.3–16.7 | Mean = 16.6 95% CI = 16.0–17.2 | β = −0.50 | −1.79-0.77 | 0.44 |